NFKB1 and colitis: The tripeptide KVP was used by Dalmasso et al. (2008) to inhibit pro-inflammatory cytokine secretion through the NFκB and mitogen-activated protein (MAP) kinase pathway in intestinal epithelial and T cells and eventually attenuate dextran sulfate sodium (DSS)/2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice.